Project Grant 2401913
Award Date
12/15/24
Completion Date
11/30/27
Dollars Obligated
$500K
Funding Federal Agency
Office of Integrative Activities
Awarding Federal Agency
Division of Chemical, Bioengineering, Environmental, and Transport System
Federal Grant Program
47.083
Assistance Type
Project Grant
Place of Performance
Montgomery, AL 36104, USA
Similar Awards
This $431,220 National Science Foundation project grant supports the development of a novel part-brain, part-engineered gas sensor for noninvasive detection of lung cancer at Michigan State University from February 1, 2023 to January 31, 2028. The grant is funded through the NSF Directorate for Engineering's Engineering program (CFDA 47.041), which seeks to foster innovation and excellence in engineering research.
Specifically, the university will develop a gas sensing device that utilizes...
North Dakota State University will develop a point-of-care biosensor device for early detection of pancreatic cancer under a $278,820 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (NSF TIP, CFDA 47.084). The university aims to efficiently and accurately detect circulating microRNA biomarkers that have been linked to early pancreatic cancer using an electric field-based, fluorescent disposable sensor. If successful, the sensors could...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) project grant for $274,990 aims to develop a prototype endoscope diagnostic cancer sensor using laser-activated plasmonic nanobubbles (PNB). The project integrates PNB sensors into a medical device platform and a standard clinical endoscope to perform minimally invasive, optically-based lung cancer diagnostic procedures. The objective is to develop a...
The National Science Foundation (NSF) awarded a $274,750 Small Business Innovation Research (SBIR) Phase I grant to Amplified Sciences Inc. on March 15, 2024 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a surface-enhanced Raman spectroscopy (SERS)-based diagnostic platform to detect and monitor multiple inflammatory biomarkers associated with various cancers. Key objectives include: 1) synthesizing ultrasensitive SERS-active dye...
The National Cancer Institute (NCI) awarded a $1,280,908 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Exai Bio Inc., a small disadvantaged business located in Palo Alto, California. The funding will support the development and testing of a novel assay and artificial intelligence (AI) model for early detection of non-small cell lung cancer (NSCLC) and prediction of disease subtypes using a proprietary class of small RNAs called orphan non-coding RNAs (OncRNAs). This...
The National Science Foundation (NSF) awarded a $650,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of Illinois for the development of a bioinspired multispectral imaging sensor to support real-time intraoperative detection of cancer. The award aims to create a novel sensor that integrates perovskite nanocrystals and optical metasurfaces to simultaneously detect endogenous cancer biomarkers in the UV spectrum and exogenous...
This $1,200,000 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) supports the development of innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics.
The key objectives of this 4-year project are to: 1) develop molecular engineering techniques for in-situ signal amplification of aptamer biosensors using DNA origami nanotechnology; 2)...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
The National Science Foundation (NSF), under its Engineering program (CFDA 47.041), awarded a $429,832 Project Grant to the University of Massachusetts (UMass) to develop a novel method for rapid and sensitive detection of nucleic acids such as DNA and RNA. The main objectives of the 5-year project are to:
Determine the nanomechanoelectrical transduction principle of nucleic-acid nanostructures tethered to a graphene transistor and oscillating in an electric field.
Achieve rapid,...
The National Science Foundation (NSF) awarded a $400,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of South Florida (USF) to develop a hybrid and modular electronic nose (e-nose) system for non-invasive medical diagnostic applications. The project aims to converge research on gas sensing and artificial intelligence/machine learning technologies to create an advanced tool for detecting volatile organic compounds as health...